Company Analysis

Pulse Biosciences, Inc (PLSE)

Nasdaq: PLSE · Surgical & Medical Instruments & Apparatus · Hayward, CA · filing with the SEC since 2014
Grade3.3
◀ Past 2.4● Present 2.8▶ Future 4.7
2 est.

Who runs Pulse Biosciences, Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Laviolette Paul A
Chief Executive Officer. First filing Aug 2024, latest May 11, 2026, 2 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
23 people on the record since 2016
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Teplitsky Liane RaeChief Operating OfficerAug 2026Sep 2, 2026none
Skinner JonChief Financial OfficerAug 2026Aug 28, 2026none
Laviolette Paul AChief Executive OfficerAug 2024May 11, 2026none
Uecker DarrinChief Technology OfficerMay 2016Apr 3, 2026none
Danahy Kevin PatrickChief Commercial OfficerMar 2022Feb 23, 20268 · $3.0M
Weber StevenPrincipal Accounting OfficerJul 2025Jul 16, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Duggan Robert WdirectorFeb 2017Jun 15, 2026none
Sainz MariadirectorFeb 2026Jun 15, 2026none
Soni Manmeet SinghdirectorNov 2017Jun 15, 2026none
Van Den Broek RicharddirectorAug 2020Jun 15, 2026none
Zanganeh MakydirectorFeb 2017Jun 15, 2026none
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PLSE · research, not advice